Na, Jin Hee Koo, Heebeom Lee, Sangmin Han, Seung Jin Lee, Kyung Eun Kim, Sunjin Lee, Haeshin Lee, Seulki Choi, Kuiwon Kwon, Ick Chan Kim, Kwangmeyung 2024-01-20T03:02:52Z 2024-01-20T03:02:52Z 2021-09-04 2016-11 1543-8384 https://pubs.kist.re.kr/handle/201004/123516 Herein, we elucidated the mechanisms and key factors for the tumor-targeting ability of nanoparticles that presented high targeting efficiency for liver tumor. We used several different nanoparticles with sizes of 200-300 nm, including liposome nanoparticles (LNPs), polystyrene nanoparticles (PNPs) and glycol chitosan-5 beta-cholanic acid nanoparticles (CNPs). Their sizes are suitable for the enhanced permeation and retention (EPR) effect in literature. Different in vitro characteristics, such as the particle structure, stability, and bioinertness, were carefully analyzed with and without serum proteins. Also, pH-dependent tumor cell uptakes of nanoparticles were studied using fluorescence microscopy. Importantly, CNPs had sufficient stability and bioinertness to maintain their nanoparticle structure in the bloodstream, and they also presented prolonged circulation time in the body (blood circulation half-life T-1/2 = about 12.2 h), compared to the control nanoparticles. Finally, employing liver tumor bearing mice, we also observed that CNPs had excellent liver tumor targeting ability in vivo, while LNPs and PNPs demonstrated lower tumor-targeting efficiency due to the nonspecific accumulation in normal liver tissue. Liver tumor models were produced by laparotomy and direct injection of HT29 tumor cells into the left lobe of the liver of athymic nude mice. This study provides valuable information concerning the key factors for the tumor-targeting ability of nanoparticles such as stability, bioinertness, and rapid cellular uptake at targeted tumor tissues. English AMER CHEMICAL SOC FREE CLICK CHEMISTRY IN-VIVO MULTIFUNCTIONAL NANOPARTICLES POLYMERIC NANOPARTICLES DRUG-DELIVERY MOLECULAR-WEIGHT CANCER-THERAPY GENE DELIVERY IRON-OXIDE LIPOSOMES Precise Targeting of Liver Tumor Using Glycol Chitosan Nanoparticles: Mechanisms, Key Factors, and Their Implications Article 10.1021/acs.molpharmaceut.6b00507 1 MOLECULAR PHARMACEUTICS, v.13, no.11, pp.3700 - 3711 MOLECULAR PHARMACEUTICS 13 11 3700 3711 scie scopus 000387428300010 2-s2.0-84994479631 Medicine, Research & Experimental Pharmacology & Pharmacy Research & Experimental Medicine Pharmacology & Pharmacy Article FREE CLICK CHEMISTRY IN-VIVO MULTIFUNCTIONAL NANOPARTICLES POLYMERIC NANOPARTICLES DRUG-DELIVERY MOLECULAR-WEIGHT CANCER-THERAPY GENE DELIVERY IRON-OXIDE LIPOSOMES tumor targeting nanoparticles stability liver tumor biodistribution